Jones David Scott

David Scott Jones serves as the Senior Vice President and Chief Commercial Officer at EyePoint Pharmaceuticals, Inc., a company focused on innovative ophthalmic therapeutics. His recent trading activity, as disclosed in SEC Form 4 filings, reflects a series of sale transactions with a notable concentration on EyePoint Pharmaceuticals (EYPT). Between January 24, 2024, and February 13, 2024, he reported 10 sales, with the largest transaction valued at approximately $652.3K, demonstrating a clear pattern of divestment during this period.